Cytox
Developing transformational prognostic technology that may contribute to the assessment of an individual's risk of developing dementias such as Alzheimer's disease.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD21—32m (Dealroom.co estimates Jun 2017.)
Company register number 05149130
Oxford England (HQ)
Authorizing premium user...